Sign inJoin waitlistJoin the waitlist

JM

John Mullinax

Associate Program Director · University of South Florida Morsani College of Medicine

Credentials: · · · ·

History

University of South Florida Morsani College of Medicine
Present
UPMC Medical Education
Present
Program Administrator · University of South Florida Morsani College of Medicine
Present

Complex General Surgical Oncology
University of South Florida Morsani College of Medicine
2012–2014
General Surgery
University of South Florida Morsani College of Medicine
2007–2012
USF Health Morsani College of Medicine
2003–2007

Research

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Nature Medicine · 2021 · 374 citations
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma
Blood · 2021 · 240 citations
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
Annals of Surgical Oncology · 2021 · 221 citations

AS
Amod Sarnaik
16 papers
Jonathan Zager
13 papers
IA
Itzhak Avital
11 papers
Udo Rudloff
9 papers
Jonathan Hernandez
8 papers · 6 as a resident
Vernon Sondak
8 papers
AS
Alexander Stojadinovic
7 papers
AR
Alexander Rosemurgy
6 papers
AB
Andrew Brohl
6 papers
Arash Naghavi
6 papers · 3 as a resident
Kenneth Cardona
6 papers
MP
Matthew Perez
6 papers · 2 as a resident

Grants

Leveraging the Lymphocytic Infiltration of Soft Tissue Sarcoma for Autologous Cellular Immunotherapy
National Cancer Institute · K08
Contact PI · $1.2M · h. Lee Moffitt Cancer Ctr & Res Inst
2020–2026

Clinical trials

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2019–2023
Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma
Principal investigator · Terminated · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2019–2021